DSpace@İnönü

Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated

Basit öğe kaydını göster

dc.contributor.author Efe, C
dc.contributor.author Tascilar, K
dc.contributor.author Henriksson, I
dc.contributor.author Lytvyak, E
dc.contributor.author Alalkim, F
dc.contributor.author Trivedi, H
dc.contributor.author Eren, F
dc.contributor.author Eliasson, J
dc.contributor.author Beretta-Piccoli, BT
dc.contributor.author Fischer, J
dc.contributor.author Caliskan, AR
dc.contributor.author Chayanupatkul, M
dc.contributor.author Coppo, C
dc.contributor.author Ytting, H
dc.contributor.author Purnak, T
dc.contributor.author Muratori, L
dc.contributor.author Werner, M
dc.contributor.author Muratori, P
dc.contributor.author Rorsman, F
dc.contributor.author Onnerhag, K
dc.contributor.author Gunsar, F
dc.contributor.author Nilsson, E
dc.contributor.author Heurgue-Berlot, A
dc.contributor.author Guzelbulut, F
dc.contributor.author Demir, N
dc.contributor.author Gonen, C
dc.contributor.author Semela, D
dc.contributor.author Aladag, M
dc.contributor.author Kiyici, M
dc.contributor.author Schiano, T
dc.contributor.author Montano-Loza, A
dc.contributor.author Berg, T
dc.contributor.author Ozaslan, E
dc.contributor.author Yoshida, E
dc.contributor.author Bonder, A
dc.contributor.author Marschall, HU
dc.contributor.author Wahlin, S
dc.date.accessioned 2022-08-12T13:20:55Z
dc.date.available 2022-08-12T13:20:55Z
dc.date.issued 2019
dc.identifier.uri http://hdl.handle.net/11616/61040
dc.description.abstract INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring systems have been proposed for risk prediction in PBC, but these have not been validated in large external cohorts. METHODS: We performed a study on data of 1746 UDCA-treated patients with PBC from 25 centers in Europe, United States, and Canada. The prognostic performance of the risk scoring systems (GLOBE and UK-PBC) and the UDCA response criteria (Barcelona, Paris I, Paris II, Rotterdam, and Toronto) were evaluated. We regarded cirrhosis-related complications (ascites, variceal bleeding, and/or hepatic encephalopathy) as clinical end points. RESULTS: A total of 171 patients reached a clinical end point during a median 7 years (range 1-16 years) of follow-up. The 5-, 10- and 15-year adverse outcome-free survivals were 95%, 85%, and 77%. The GLOBE and UK-PBC scores predicted cirrhosis-related complications better than the UDCA response criteria. The hazard ratio (HR) for a 1 standard deviation increase was HR 5.05 (95% confidence interval (CI): 4.43-5.74, P < 0.001) for the GLOBE score and HR 3.39 (95% CI: 3.10-3.72, P < 0.001) for the UK-PBC score. Overall, the GLOBE and UK-PBC risk scores showed similar and excellent prognostic performance (C-statistic, 0.93; 95% CI: 0.91%-95% vs 0.94; 95% CI: 0.91%-0.96%). DISCUSSION: In our international, multicenter PBC cohort, the GLOBE and UK-PBC risk scoring systems were good predictors of future cirrhosis-related complications.
dc.description.abstract C1 [Efe, Cumali; Demir, Nurhan] Gazi Yasargil Educ & Res Hosp, Dept Gastroenterol, Diyarbakir, Turkey.
dc.description.abstract [Tascilar, Koray] Istanbul Okmeydani Educ & Res Hosp, Dept Rheumatol, Istanbul, Turkey.
dc.description.abstract [Henriksson, Ida] Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden.
dc.description.abstract [Lytvyak, Ellina; Montano-Loza, Aldo] Univ Alberta, Div Gastroenterol, Edmonton, AB, Canada.
dc.description.abstract [Lytvyak, Ellina; Montano-Loza, Aldo] Univ Alberta, Liver Unit, Edmonton, AB, Canada.
dc.description.abstract [Alalkim, Fatema; Yoshida, Eric] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada.
dc.description.abstract [Alalkim, Fatema; Yoshida, Eric] Vancouver Gen Hosp, Vancouver, BC, Canada.
dc.description.abstract [Trivedi, Hirsh; Bonder, Alan] Harvard Med Sch, Beth Israel Med Ctr, Div GI & Hepatol, Boston, MA 02115 USA.
dc.description.abstract [Eren, Fatih; Kiyici, Murat] Uludag Univ, Med Fac, Dept Gastroenterol, Bursa, Turkey.
dc.description.abstract [Eliasson, Johanna; Ytting, Henriette] Univ Copenhagen, Rigshosp, Dept Hepatol, Copenhagen, Denmark.
dc.description.abstract [Beretta-Piccoli, Benedetta Terziroli] Epatoctr Ticino, Dept Internal Med, Lugano, Switzerland.
dc.description.abstract [Fischer, Janett; Berg, Thomas] Univ Clin Leipzig, Sect Hepatol, Clin Gastroenterol, Leipzig, Germany.
dc.description.abstract [Caliskan, Ali Riza; Aladag, Murat] Inonu Univ, Sch Med, Dept Gastroenterol, Malatya, Turkey.
dc.description.abstract [Chayanupatkul, Maneerat; Schiano, Thomas] Mt Sinai Med Ctr, Div Liver Dis, New York, NY 10029 USA.
dc.description.abstract [Chayanupatkul, Maneerat] Chulalongkorn Univ, Fac Med, Bangkok, Thailand.
dc.description.abstract [Coppo, Claudia; Muratori, Luigi; Muratori, Paolo] Univ Bologna, Ctr Study & Treatment Autoimmune Dis Liver & Bili, Bologna, Italy.
dc.description.abstract [Purnak, Tugrul] Hacettepe Univ, Dept Gastroenterol, Ankara, Turkey.
dc.description.abstract [Werner, Marten] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
dc.description.abstract [Rorsman, Fredrik] Uppsala Univ Hosp, Dept Gastroenterol & Hepatol, Uppsala, Sweden.
dc.description.abstract [Onnerhag, Kristina] Skane Univ Hosp, Dept Gastroenterol & Hepatol, Malmo, Sweden.
dc.description.abstract [Gunsar, Fulya] Ege Univ, Dept Gastroenterol, Izmir, Turkey.
dc.description.abstract [Nilsson, Emma] Lund Univ, Univ Hosp Skane, Dept Clin Sci, Gastroenterol Div, Lund, Sweden.
dc.description.abstract [Heurgue-Berlot, Alexandra] CHU Reims, Dept Hepatogastroenterol, Reims, France.
dc.description.abstract [Guzelbulut, Fatih; Gonen, Can] Haydarpasa Numune Educ & Res Hosp, Dept Gastroenterol, Istanbul, Turkey.
dc.description.abstract [Semela, David] Kantonsspital St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland.
dc.description.abstract [Ozaslan, Ersan] Numune Res & Educ Hosp, Dept Gastroenterol, Ankara, Turkey.
dc.description.abstract [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.
dc.description.abstract [Wahlin, Staffan] Karolinska Inst, Ctr Digest Dis, Hepatol Div, Stockholm, Sweden.
dc.description.abstract [Wahlin, Staffan] Karolinska Univ Hosp, Stockholm, Sweden.
dc.source AMERICAN JOURNAL OF GASTROENTEROLOGY
dc.title Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated
dc.title Patients With Primary Biliary Cholangitis


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster